Table 1 Distribution of demographic, clinical and laboratory data of study patients by gender
Parameter | Male n = 137 | Female n = 165 | P-value |
|---|---|---|---|
African | 130 (94.9%) | 160 (97.0%) | 0.282 |
Rural | 60 (43.8%) | 77 (46.7%) | 0.618 |
Smoking # | 24/134 (17.9%) | 2/158 (1.4%) | <0.001 |
Age (years) | 45.0 ± 17.6 | 48.5 ± 16.8 | 0.055 |
Systolic blood pressure (mmHg) | 144.6 ± 28.3 | 141.1 ± 25.5 | 0.362 |
Diastolic blood pressure (mmHg) | 84.2 ± 18.1 | 81.0 ± 19.0 | 0.153 |
BMI (kg/m 2 ) # | 25.4 ± 5.5 | 29.4 ± 7.9 | <0.001 |
Waist circumference (cm) # | 92.5 ± 15.2 | 98.5 ± 20.6 | 0.021 |
Overweight/obese # | 55/101 (54.5%) | 108/125 (86.4%) | <0.001 |
( % with data ) | (73.7) | (75.8) | |
Dyslipidaemia | 40 (29.2%) | 78 (47.9%) | 0.001 |
Total cholesterol (mmol/l)* | 4.1 (3.5-5.1) | 4.5 (3.7-6.0) | 0.009 |
Serum creatinine (μmol/l)* | 215 (116–464) | 173 (90–336) | 0.009 |
MDRD-eGFR (ml/min/1.73 m 2 )* | 28.5 (11.8-61.9) | 30.4 (13.7-63.5) | 0.906 |
% with MDRD-eGFR <60 | 100 (73.0%) | 119 (72.6%) | 0.933 |
% with MDRD-eGFR <30 | 68 (49.6%) | 85 (51.5%) | 0.745 |
% with MDRD-eGFR <15 | 44 (31.9%) | 49 (29.9%) | 0.707 |
Proteinuria | 66 (48.2%) | 68 (41.2%) | 0.225 |
Serum albumin (g/l) | 30.6 ± 9.6 | 31.3 ± 8.8 | 0.530 |
Haemoglobin (g/dl) | 10.7 ± 2.7 | 10.3 ± 2.4 | 0.183 |